Bachem Holding AG

OTCPK:BCHMF (Switzerland)   Ordinary Shares
$ 97.06 +9.551 (+10.91%) 10:08 PM EST
56.93
P/B:
5.71
Volume:
900.00
Avg Vol (2M):
300.00
Also Trade In:
Volume:
900.00
Avg Vol (2M):
300.00
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for BCHMF ( Bachem Holding AG ) from 2011 to May 22 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Bachem Holding AG stock (BCHMF) PE ratio as of May 22 2024 is 56.93. More Details

Bachem Holding AG (BCHMF) PE Ratio (TTM) Chart

To

Bachem Holding AG (BCHMF) PE Ratio (TTM) Historical Data

Total 1232
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Bachem Holding AG PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-05-22 56.9 2024-03-19 49.8
2024-05-21 56.9 2024-03-18 49.8
2024-05-20 51.3 2024-03-15 49.8
2024-05-17 51.3 2024-03-14 49.8
2024-05-16 51.3 2024-03-13 49.8
2024-05-15 51.3 2024-03-12 49.8
2024-05-14 51.3 2024-03-11 49.8
2024-05-13 51.3 2024-03-08 49.8
2024-05-10 51.3 2024-03-07 49.8
2024-05-09 51.3 2024-03-06 49.8
2024-05-08 51.3 2024-03-05 49.8
2024-05-07 51.3 2024-03-04 49.8
2024-05-06 51.3 2024-03-01 49.8
2024-05-03 51.3 2024-02-29 49.8
2024-05-02 51.3 2024-02-28 49.8
2024-05-01 51.3 2024-02-27 49.8
2024-04-30 51.3 2024-02-26 49.8
2024-04-29 51.3 2024-02-23 49.8
2024-04-26 51.3 2024-02-22 49.8
2024-04-25 51.5 2024-02-21 49.8
2024-04-24 49.8 2024-02-20 49.8
2024-04-23 49.8 2024-02-16 49.8
2024-04-22 49.8 2024-02-15 49.8
2024-04-19 49.8 2024-02-14 49.8
2024-04-18 49.8 2024-02-13 49.8
2024-04-17 49.8 2024-02-12 49.8
2024-04-16 49.8 2024-02-09 49.8
2024-04-15 49.8 2024-02-08 49.8
2024-04-12 49.8 2024-02-07 49.8
2024-04-11 49.8 2024-02-06 49.8
2024-04-10 49.8 2024-02-05 49.8
2024-04-09 49.8 2024-02-02 49.8
2024-04-08 49.8 2024-02-01 49.8
2024-04-05 49.8 2024-01-31 49.8
2024-04-04 49.8 2024-01-30 49.8
2024-04-03 49.8 2024-01-29 49.8
2024-04-02 49.8 2024-01-26 49.8
2024-04-01 49.8 2024-01-25 49.8
2024-03-28 49.8 2024-01-24 49.8
2024-03-27 49.8 2024-01-23 49.8
2024-03-26 49.8 2024-01-22 49.8
2024-03-25 49.8 2024-01-19 49.8
2024-03-22 49.8 2024-01-18 49.8
2024-03-21 49.8 2024-01-17 49.8
2024-03-20 49.8 2024-01-16 49.8

Bachem Holding AG (BCHMF) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Bachem Holding AG is a biochemical company that provides services to the pharmaceutical and biotechnology industry. It focuses on specializing in the development and manufacture of peptides and oligonucleotides. The group markets its products under the Bachem and Clinalfa brands. It has two geographic segments Europe/Asia and North America. Its products and services are CMC Development, Commercial API, Research and Specialities, and Services and Capabilities.